Researchers at the National Institute of Standards and Technology (www.nist.gov) have developed a new method to produce uniform, self-assembled nanocells for drug therapies, such as chemotherapy, in which dosage depends critically on the size of the nanocells. The new method uses micrometer-size channels etched into a device to produce self-assembled liposomes—a type of artificial nanocell—of specific sizes from 100 to 240 nm. A stream of lipids dissolved in alcohol is directed at an intersection of two channels while a water-based liquid containing medicines or other substances is sent toward the lipid stream from two opposing directions. Self-assembled nanocells are formed when the lipids surround the water rather than mixing with it.
As energy efficiency becomes more and more a concern for makers of electronics devices, researchers are coming up with new ways to harvest energy from sound vibration, footsteps, and even electromagnetic fields in the air.
The government wants to study your brain, and DARPA wants to use similar information to give robots true autonomy beyond any artificial intelligence developed to date. Sound like science fiction? It's not.
A quick look into the merger of two powerhouse 3D printing OEMs and the new leader in rapid prototyping solutions, Stratasys. The industrial revolution is now led by 3D printing and engineers are given the opportunity to fully maximize their design capabilities, reduce their time-to-market and functionally test prototypes cheaper, faster and easier. Bruce Bradshaw, Director of Marketing in North America, will explore the large product offering and variety of materials that will help CAD designers articulate their product design with actual, physical prototypes. This broadcast will dive deep into technical information including application specific stories from real world customers and their experiences with 3D printing. 3D Printing is